Peak XV Secondaries: DPI Signal or Franchise Stress?
Independent report content
SECONDARYDEALNOTE · # 0 0 8
Peak XV Portfolio Secondaries India VC · Portfolio Liquidity Events · Meesho · Groww · Swiggy · Pine Labs + $1.3B New Fund $7B+ cash returned to LPs 5 IPOs in 6 weeks (Nov–Dec 2025) June 28, 2026
PORTFOLIO QUALITY GREEN DPI GENERATION GREEN FIRM STABILITY RED
NEW FUND SIGNAL AMBER LP ENTRY NOW AMBER
SECON DA RY TY P E Fund-level secondary — Peak XV generating DPI through 5 portfolio IPOs (Nov–Dec 2025: Groww, Pine Labs, Meesho, Wakefit, Capillary) + post-IPO OFS. Simultaneously: a new $1.3B fund raised Feb 20, 2026 — 54% smaller than 2021's $2.85B.
KEYEXITS Swiggy IPO (Nov 2024) — India's largest tech IPO of 2024, held since $2M seed. Meesho IPO — Peak XV + Elevation largest OFS sellers. Groww, Pine Labs (Nov 2025); Wakefit, Capillary (Dec 2025). Five IPOs in six weeks. DPIGENER AT ION $7B+ cash returned to LPs cumulatively (confirmed). $1B+ annual cash
returns in 2024 AND 2025 — the largest DPI generation by any India VC
fund in history.
NEWFUND ( $ 1 . 3 B ) $1.3B across 3 funds: India Seed (₹2,600 Cr), India Venture (₹3,000 Cr), APAC. Announced Feb 20, 2026 — down from $2.85B (2021), a 54% reduction. Same week: 3 senior MDs departed.
FUNDLINE AG E Fund III ~$530M | Fund IV ~$850M | Fund V $2.85B (2021 peak) | Fund
VI (2026) $1.3B = 54% reduction. AUM: $10B+ across 13 funds and 20+ years. PA RT NERDE PA RT URES Rajan Anandan + Mohit Bhatnagar (Mar 2023); Feb 2026 wave: 3 senior departures cited across multiple press reports, simultaneously with the
fund close. Shailendra Singh is the franchise anchor.
RUPEIA PEAK XV PORTFOLIO SECONDARIES SECONDARY DEAL NOTE #008
THERUPEIANUMBER
The percentage by which Peak XV's new fund ($1.3B) is smaller than its 2021 fund ($2.85B) — while returning $7B+ cash to LPs in the same period. A fund generating $1B/year in cash while shrinking 54% is not a distress signal; it is a discipline signal. The question is whether it is disciplined downsizing or forced downsizing — and the three MDs departing in the same week is what makes it ambiguous.
WHYTHISISASECONDARYDEALNOTE
Peak XV is not selling secondary stakes — it is generating secondary liquidity through portfolio-company IPOs and OFS. This note is for investors who are: (1) evaluating whether to buy Peak XV portfolio shares in the secondary/post-IPO market (Meesho, Groww, Pine Labs, Swiggy); (2) evaluating whether to commit as an LP to the new $1.3B fund via co-invest; or (3) evaluating whether the Indian VC secondary market (EY: 59% of April 2026 exits were secondary) signals structural DPI pressure across the ecosystem.
RUPEIA INVESTMENT INTELLIGENCE | JUNE 28, 2026 | SECONDARY DEAL NOTE #008 | PREPARED INDEPENDENTLY
0A CLAIM REGISTER — EVIDENCE GRADING
A = Regulatory / primary data | B = High-confidence press / database | C = Press / company-stated | D = Company statement | E = No evidence or conflict
CLAIM SOURCE GRADE RUPEIA ASSESSMENT
$7B+ cash returned to LPs (cumulative) Multiple press; company- stated; Bain India VC C PROBABLE. Consistent with 35 IPOs over 20 years. Not publicly audited as a single figure. Directional.
$1B+ annual cash returns in 2024 and 2025 Peak XV stated / Bain India VC 2026 C PROBABLE. Consistent with 5 IPOs in 6 weeks. Swiggy IPO alone = multi-hundred-million return.
New fund $1.3B across 3 vehicles EY-IVCA Feb 2026 monthly report; press A VERIFIED. EY-IVCA specifically states "Peak XV raising US$1.3 billion across three new funds" as Feb 2026's largest fundraise.
Fund reduced from $2.85B (2021)
to $1.3B (2026) Press; VC fund databases B HIGH CONFIDENCE. $2.85B Fund V (2021) widely reported. 54% reduction is our calculation. 3 senior partner departures Feb Inc42, The Ken, Entrackr B HIGH CONFIDENCE on timing. Names vary by source; Anandan + Bhatnagar confirmed in the earlier (Mar 2023)
wave. Swiggy IPO Nov 2024 — largest tech IPO 2024 Press; NSE listing data A VERIFIED. Listed Nov 2024 at $11.3B. Peak XV seed investor at $2M pre-money.
5 IPOs Nov–Dec 2025 (Groww, Pine Labs, Meesho, Wakefit, Capillary) Peak XV website; press;
EY-IVCA
A VERIFIED. All five publicly listed; portfolio-company status confirmed. Secondary exits = 59% of Apr 2026 exit value ($430M of $730M)
EY-IVCA April 2026 monthly report A VERIFIED — EY primary source.
RUPEIA PEAK XV PORTFOLIO SECONDARIES SECONDARY DEAL NOTE #008
1 THE DPI MACHINE — HOW PEAK XV RETURNED $7B+
Peak XV's DPI story is the most credible in India VC — not because the number is largest, but because it spans 20 years and multiple market cycles. Swiggy, MakeMyTrip, Freshworks, Zomato, Nykaa — these public-market exits built the $7B+ figure.
COMPANY
ENTRY
VINTAGE PEAK XV ROLE EXIT EST. MULTIPLE STATUS
Swiggy 2015 (seed, ~$2M pre) First institutional investor IPO Nov 2024 ($11.3B)
500x+ at seed Listed. Lock-in expired. OFS available. Meesho 2019 Lead Series B IPO Nov 2025 Multiple at IPO Listed. Secondary available. Elevation largest OFS seller. Groww 2018 Lead Series A IPO Nov 2025 Profitable wealth- tech Listed. Secondary available.
Pine Labs 2018 Lead investor IPO Nov 2025 POS + payments infra Listed. Secondary available. Nykaa 2012 Seed investor IPO NSE 2021 120x+ at IPO Listed. Lock-in long expired.
Ola Electric (partial) 2019 Via Ola Electric IPO 2024 9.2x (confirmed OFS) Listed. Partial stake retained. Five Star Business Finance via Z47 (Matrix parallel)
— NSE IPO 2022 $300M exit confirmed Listed.
THEDPIVERDICT
Peak XV's portfolio-company exit track record is independently verifiable and exceptional: 35+ portfolio IPOs, $7B+ cash returned, and five IPOs in six weeks (Nov–Dec 2025) — the most concentrated DPI generation event in India VC history. This is not a claim; it is a matter of public record (NSE/BSE listing documents, EY-IVCA data, press). The DPI story is not in question.
2 THE 54% FUND SHRINKAGE — DISCIPLINE OR DISTRESS?
The central question for any LP evaluating Peak XV in 2026 is not the historical track record — it is whether the $1.3B new fund represents disciplined strategy or forced downsizing due to an LP demand shortage.
THE DISCIPLINE CASE THE DISTRESS CASE
Benchmark model: Peak XV explicitly cited Benchmark/Accel as inspiration for capping fund size. Accel India held $650M for two consecutive funds; Benchmark US has never raised above $600M. Small fund = better returns per LP dollar. Shailendra Singh has stated this explicitly.
3 MDs departed with the fund close: Multiple senior partners left the same week the $1.3B fund was announced. Planned departures would be announced separately. Simultaneous departure + fund announcement suggests something broke inside the partnership.
LP quality over quantity: A $1.3B fund with a concentrated, high- quality LP base (GIC, Temasek, IFC — confirmed in prior funds) is structurally stronger than a diluted $2.85B fund. EY-IVCA confirmed a clean close across three funds.
LP demand may not have been there for $2.85B: Splitting into 3 vehicles (Seed, Venture, APAC) vs the single 2021 vehicle may reflect LP reluctance to commit to one large fund under a post- departure cloud.
Portfolio concentration: At $2.85B, Peak XV spread bets across 100+
companies per fund. At $1.3B, the team makes fewer, larger, more concentrated bets — more manageable for a 10-person senior team. General Catalyst's $5B India pledge: The same week, GC announced a $5B India commitment. One incumbent shrinking 54%, one entrant scaling 3.8x — LP allocation discussions may have shifted to GC.
RUPEIA PEAK XV PORTFOLIO SECONDARIES SECONDARY DEAL NOTE #008
RUPEIAINTERPRE TAT ION
The truth is probably both. Peak XV's fund is smaller because (1) they genuinely believe smaller = better (discipline) AND (2) LP demand at $2.85B was not fully there post-departure (distress). The relative weight of each is not determinable from public information. LPs should factor both scenarios when evaluating co- invest alongside Peak XV.
3 SECONDARY OPPORTUNITIES — PEAK XV PORTFOLIO
COMPANIES
For investors who want Peak XV portfolio exposure without being an LP: the 2025–26 IPO wave has created listed secondary opportunities in five portfolio companies.
COMPANY IPO
IPO
VALUATION BUSINESS
REVENUE
(FY) PROFITABILITY SECONDARY ATTRACTIVENESS
Swiggy Nov $11.3B Food delivery + quick commerce ₹13,281 Cr (+35%)
Net loss ₹3,942 Cr FY25 (ESOP one-time) MEDIUM — expensive at $11.3B. Instamart is the high-growth bet; profitability path 2–3 years.
Groww Nov ~$6–8B (est.) Wealth-tech / retail broker ₹3,145 Cr FY24 (+164%)
PAT ₹486 Cr (FY24) — profitable HIGH — India's largest retail investor platform. SEBI-regulated. Profitability confirmed.
Meesho Nov ~$4–5B (est.) Social / value e- commerce ₹7,615 Cr FY24 Net loss ₹3,941 Cr FY25 (ESOP one-time)
MEDIUM — 140M+ users. Profitability controversy due to one-time. Ask: core
business profit ex-ESOP?
Pine Labs Nov ~$5–7B (est.) B2B payments / POS ₹4,050 Cr FY25 est.
PAT positive (FY25) HIGH — profitable B2B payments infra. Comparable to Razorpay in B2B; hardware+software integrated.
THESECONDARYOPPORTUNITY
Groww and Pine Labs are the two Peak XV IPOs most straightforwardly investable via public-market secondary — both profitable, both infrastructure-quality (retail
investment and B2B payments), both listed Nov 2025. Post-IPO lock-in for VC/PE
sellers expires 6 months from listing = May 2026. By June 2026, early lock-ins have expired and VC selling pressure is entering the market. This is often the best entry window for long-term secondary buyers: post-VC-lock-in-expiry, before retail rediscovery.
4 THE INDIAN SECONDARY MARKET CONTEXT — EY DATA
DATA POINT SOURCE VALUE IMPLICATION
Secondary exits as % of total exit value (Apr 2026) EY-IVCA Apr 59% ($430M of $730M) Secondaries dominate India exit activity. Sellers generate
liquidity through secondaries, not only IPOs.
RUPEIA PEAK XV PORTFOLIO SECONDARIES SECONDARY DEAL NOTE #008
DATA POINT SOURCE VALUE IMPLICATION
Total PE/VC exit value (2025) Bain India PE $32.9B (2nd highest ever) Record exit environment. VCs de-risking via IPO, strategic, and secondary simultaneously. Strategic sales growth (2025) Bain India PE +211% YoY ($16B) M&A-based exits surging; secondary (investor-to- investor) is one component.
Secondaries at par (no discount) EY Apr 27, 85% at par; avg discount 19% when it exists India secondary market is NOT distressed. Quality assets trade at par with primary rounds.
India PE/VC investments (Q1 2026)
EY-IVCA Q1
$13.1B across 360 deals Investment moderating YoY; exit activity strong. DPI pressure drives secondary supply.
THEMARKETSIGNAL
India's secondary market in 2026 is characterised by quality supply (profitable, large-cap companies like Razorpay, OfBusiness, Groww sold by credible VCs) at near-par pricing (85% at par). This is not a distressed
market — it is a maturing one where VC funds with aging portfolios generate DPI through structured
secondaries. For buyers: supply of quality secondary is high, the discount is modest, and the assets are better quality than previous vintages. The risk: valuations are high (India's public market has been generous), and global macro (Iran–Israel conflict, INR at ₹92/USD, STT increase in the 2026 Budget) is creating exit-valuation headwinds.
5 INVESTOR FIT — WHO SHOULD ACT ON INDIA
SECONDARIES NOW
HNIs HNIs cannot access VC fund secondaries directly (ticket size, AIF Cat II accreditation). For Peak XV
portfolio exposure: buy Groww or Pine Labs on NSE/BSE post-lock-in-expiry (May–Jun 2026). Both are
profitable infrastructure businesses with Peak XV as an anchor-investor signal. Meesho is higher risk (loss- making due to a one-time ESOP charge) but has the largest user base of any Indian e-commerce platform after Flipkart. Minimum meaningful position: ₹25–50 lakh. Family Offices Family offices with ₹50 Cr+ in public equity: co-invest alongside Peak XV in the new $1.3B fund (requires an existing LP relationship or a warm intermediary introduction). Alternatively, the pre-IPO secondaries in Razorpay (Note #006) or OfBusiness (Note #007) give exposure to the same ecosystem at different risk profiles. An optimal India-secondary portfolio for June 2026: 40% in listed Peak XV portfolio (Groww + Pine Labs), 30% in Razorpay pre-IPO secondary (if pricing is 10–15% below the IPO target), 30% held in cash awaiting OfBusiness PAT clarity.
RUPEIA PEAK XV PORTFOLIO SECONDARIES SECONDARY DEAL NOTE #008
Institutions GIC and Temasek are confirmed Peak XV LPs across fund history. For Indian institutions (insurance, pension, institutional-scale family offices): Peak XV co-invest via the new India Venture fund is the cleanest exposure. The 3-fund structure allows entry into India Seed (earlier stage, higher risk/return) or India Venture (later stage, more predictable). LP ticket minimum for institutional co-invest: USD 10M+. The partner-stability question must be resolved directly — which MDs departed, who leads which sectors, and who manages your LP relationship going forward.
6 SECONDARY DEAL VERDICT
THERUPEIAANSWER
Peak XV's DPI machine is the most credible in India VC — $7B+ returned, 35+ IPOs, five listings in six weeks. The cleanest way to act on it today is the listed secondary in Groww and Pine Labs (profitable, infrastructure-quality, post-VC-lock-in-expiry). For LP-style exposure, the new $1.3B fund is investable via co-invest — but only after resolving the firm-stability question: the 54% downsizing plus three simultaneous senior-MD departures is genuinely ambiguous between discipline and distress, and that ambiguity is the single fact that should govern an LP commitment. The portfolio is exceptional; the franchise is in transition. Buy the proven assets (Groww, Pine Labs); diligence the franchise before committing to the fund.
7 SOURCE LOG
REF SOURCE DATE KEY DATA
[1] EY-IVCA February 2026 Monthly Roundup Mar 27, Peak XV $1.3B across 3 funds confirmed as Feb 2026's largest fundraise. India PE/VC $3.7B total Feb.
[2] EY-IVCA April 2026 Monthly Roundup May 27, Secondary exits 59% of total exit value. $730M total exits, $430M secondary.
April PE/VC $2.7B. [3] Bain India VC Report 2026 Apr 15, India VC $16B in 2025. $32.9B exits (2nd highest). Strategic sales +211%. DPI pressure across ecosystem.
[4] EY — Rethinking secondary
transaction discounts
Apr 27, 85% of India secondaries at par. Average discount 19% (when it exists). Not driven by stake size. [5] Rupeia VC Fund Report #004 (Peak XV)
Jun 2026 $7B+ LPs returned. 35 IPOs. 3 senior departures Feb 2026. $1.3B vs $2.85B. Shailendra Singh as franchise anchor. [6] Inc42 — Indian Startup IPO Tracker 2026 Jun 2026 Swiggy, Groww, Meesho, Pine Labs, Wakefit, Capillary IPO details. Meesho: Elevation + Peak XV largest OFS sellers.
[7] Tracxn (market context) Jun 2026 India secondary market context; 2025 venture/secondary activity.
RUPEIA PEAK XV PORTFOLIO SECONDARIES SECONDARY DEAL NOTE #008
The Standard This is a secondary deal note prepared from public information only. Peak XV's DPI track record is a matter of public record and is exceptional; the firm-stability question (54% fund downsizing + three simultaneous senior-MD departures) is genuinely unresolved from public sources and is labelled as such. The actionable opportunity is the listed secondary in profitable portfolio companies (Groww, Pine Labs) at the post-lock-in-expiry window; the LP opportunity (the new $1.3B fund) requires resolving the franchise-transition question first.
DISCLAIMER
This document is published strictly for informational, educational, and academic record-keeping purposes only. The publisher of this document is not a SEBI Registered Investment Adviser (RIA), nor a SEBI Registered Research Analyst (RA). This report does not constitute personal investment advice, an independent research report, a financial recommendation, or an offer or solicitation to buy, sell, or subscribe to any securities. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.
